Brief: Spago: Promising results in toxicological pilot studies with SpagoPix

Spago Nanomedical AB (publ)

17/02/2017 12:55

Feb 17 (Reuters) - Spago Nanomedical AB (publ)  SPAGO.ST : 
    * Collective data from recently completed toxicity studies 
show that the product candidate SN132D can be given safely at 
doses that widely exceeds the expected clinical dose 
 
 
 
     
 Source text: http://bit.ly/2lemxcF 
     
 Further company coverage:  SPAGO.ST   
    
 
 
 (Gdynia Newsroom) 
 ((Gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))